N. C. Thalassinos

567 total citations
22 papers, 416 citations indexed

About

N. C. Thalassinos is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, N. C. Thalassinos has authored 22 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in N. C. Thalassinos's work include Pituitary Gland Disorders and Treatments (5 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Bone health and treatments (3 papers). N. C. Thalassinos is often cited by papers focused on Pituitary Gland Disorders and Treatments (5 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Bone health and treatments (3 papers). N. C. Thalassinos collaborates with scholars based in Greece, United Kingdom and France. N. C. Thalassinos's co-authors include Eftychia Koukkou, George Dimitriadis, Panagiota Mitrou, S. Raptis, Demosthenes B. Panagiotakos, Eirini Maratou, Vaia Lambadiari, Eleni Boutati, G. F. Joplin and Stylianos Tsagarakis and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Osteoporosis International.

In The Last Decade

N. C. Thalassinos

22 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. C. Thalassinos Greece 11 231 75 64 56 52 22 416
R. Hehrmann Germany 11 203 0.9× 50 0.7× 61 1.0× 42 0.8× 41 0.8× 45 400
C.C. Alevizaki Greece 10 255 1.1× 149 2.0× 76 1.2× 27 0.5× 69 1.3× 20 444
Juraj Payer Slovakia 12 180 0.8× 45 0.6× 99 1.5× 57 1.0× 64 1.2× 56 384
Claudia Campusano Chile 11 104 0.5× 78 1.0× 83 1.3× 36 0.6× 30 0.6× 41 323
Francisco Javier Maravall Spain 8 223 1.0× 39 0.5× 49 0.8× 95 1.7× 24 0.5× 9 357
Cevad Şekuri Türkiye 12 154 0.7× 75 1.0× 42 0.7× 86 1.5× 83 1.6× 31 471
Anil Bhansali India 12 122 0.5× 82 1.1× 66 1.0× 44 0.8× 51 1.0× 41 362
J. Rodríguez‐Arnao United Kingdom 11 368 1.6× 49 0.7× 76 1.2× 82 1.5× 51 1.0× 13 479
Ji Young Joung South Korea 15 315 1.4× 126 1.7× 41 0.6× 28 0.5× 50 1.0× 23 428
Graziamaria Ubertini Italy 11 243 1.1× 108 1.4× 105 1.6× 27 0.5× 65 1.3× 35 384

Countries citing papers authored by N. C. Thalassinos

Since Specialization
Citations

This map shows the geographic impact of N. C. Thalassinos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. C. Thalassinos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. C. Thalassinos more than expected).

Fields of papers citing papers by N. C. Thalassinos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. C. Thalassinos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. C. Thalassinos. The network helps show where N. C. Thalassinos may publish in the future.

Co-authorship network of co-authors of N. C. Thalassinos

This figure shows the co-authorship network connecting the top 25 collaborators of N. C. Thalassinos. A scholar is included among the top collaborators of N. C. Thalassinos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. C. Thalassinos. N. C. Thalassinos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, Cyrus, Franz Jakob, E. Martín‐Mola, et al.. (2007). Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporosis International. 19(4). 493–501. 35 indexed citations
2.
Dimitriadis, George, Panagiota Mitrou, Vaia Lambadiari, et al.. (2006). Insulin Action in Adipose Tissue and Muscle in Hypothyroidism. The Journal of Clinical Endocrinology & Metabolism. 91(12). 4930–4937. 174 indexed citations
3.
Pratsinis, Harris, et al.. (2006). The Unexpected Anabolic Phenotype and Extended Longevity of Skin Fibroblasts after Chronic Glucocorticoid Excess. Dose-Response. 4(2). 133–44. 5 indexed citations
4.
Tzanela, Marinella, et al.. (2005). Growth hormone binding protein and acid labile subunit levels in the assessment of acromegaly treatment. HORMONES. 4(3). 148–154. 4 indexed citations
5.
Pratsinis, Harris, Stylianos Tsagarakis, Niki Karavitaki, et al.. (2005). The impact of chronic in vivo glucocorticoid excess on the functional characteristics of human skin fibroblasts obtained from patients with endogenous Cushing’s syndrome. European Journal of Endocrinology. 152(6). 895–902. 11 indexed citations
6.
Tzanela, Marinella, et al.. (2004). Symptomatic pheochromocytoma with normal urinary catecholamine metabolites. HORMONES. 3(2). 132–137. 4 indexed citations
7.
Tzanela, Marinella, et al.. (2004). Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome. Clinical Endocrinology. 60(3). 309–314. 26 indexed citations
8.
Pratsinis, Harris, et al.. (2002). Chronic in vivo exposure to glucocorticoids prolongs cellular lifespan: the case of Cushing's syndrome-patients' fibroblasts. Experimental Gerontology. 37(10-11). 1237–1245. 13 indexed citations
9.
Tsagarakis, S., et al.. (1995). Successful localization of an occult ACTH‐secreting bronchial carcinoid tumour with 111indium‐DTPA labelled octreotide. Clinical Endocrinology. 43(6). 763–767. 10 indexed citations
10.
Thalassinos, N. C., et al.. (1993). Effect of 131 I treatment on the calcitonin response to calcium infusion in hyperthyroid patients. Clinical Endocrinology. 38(1). 25–28. 7 indexed citations
11.
Thalassinos, N. C., et al.. (1991). [Diabetes mellitus and periodontium. 1. Prevalence of periodontal disease in young insulin-dependent diabetics].. PubMed. 47(2). 73–86. 3 indexed citations
12.
Avgerinos, Alec, et al.. (1984). Plasma Alpha-Lipoprotein Pattern and LCAT Activity in Acute Viral Hepatitis in Children. Scandinavian Journal of Gastroenterology. 19(1). 76–80. 12 indexed citations
13.
Thalassinos, N. C., Donald H. Gutteridge, G. F. Joplin, & T. R. Fraser. (1982). Calcium Balance in Osteoporotic Patients on Long-Term Oral Calcium Therapy with and without Sex Hormones. Clinical Science. 62(2). 221–226. 8 indexed citations
14.
Goolden, A. W. G., E. D. Williams, & N. C. Thalassinos. (1973). STUDIES OF THYROID FUNCTION USING 99Tcm IN THYROTOXIC PATIENTS DURING TREATMENT WITH ANTITHYROID DRUGS. Clinical Endocrinology. 2(1). 65–73. 13 indexed citations
15.
Thalassinos, N. C., et al.. (1970). Secondary Hyperparathyroidism in Osteomalacia. BMJ. 1(5688). 76–79. 7 indexed citations
16.
Thalassinos, N. C., et al.. (1970). Urinary Excretion ofPhosphate inNormalChildren. 1 indexed citations
17.
Thalassinos, N. C., et al.. (1970). Urinary Excretion of Phosphate in Normal Children. Archives of Disease in Childhood. 45(240). 269–272. 10 indexed citations
18.
Bordier, P, et al.. (1969). A case of mild hyperparathyroidism in childhood.. Archives of Disease in Childhood. 44(236). 521–526. 5 indexed citations
19.
Hartog, M., Beth Redfern, N. C. Thalassinos, et al.. (1968). Calcium Metabolism in Acromegaly. BMJ. 4(5634). 797–801. 36 indexed citations
20.
Singer, Frederick R., Giraud V. Foster, G. F. Joplin, et al.. (1968). Acute effects of administered calcitonin in man. Calcified Tissue International. 2(S1). 20–20. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026